Michael Lübbert

27.7k total citations · 1 hit paper
297 papers, 12.7k citations indexed

About

Michael Lübbert is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Lübbert has authored 297 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Hematology, 174 papers in Molecular Biology and 49 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Lübbert's work include Acute Myeloid Leukemia Research (216 papers), Epigenetics and DNA Methylation (78 papers) and Histone Deacetylase Inhibitors Research (58 papers). Michael Lübbert is often cited by papers focused on Acute Myeloid Leukemia Research (216 papers), Epigenetics and DNA Methylation (78 papers) and Histone Deacetylase Inhibitors Research (58 papers). Michael Lübbert collaborates with scholars based in Germany, United States and Netherlands. Michael Lübbert's co-authors include Barbara Deschler-Baier, Manfred Jung, Rainer Claus, Pierre W. Wijermans, Björn Hackanson, P. Wijermans, Arnold Ganser, Björn Rüter, André Bosly and F. Herrmann and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michael Lübbert

284 papers receiving 12.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

2007 540 citations Michael Lübbert, Regina Kunzmann et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Lübbert	7.4k	7.2k	2.2k	2.0k	1.6k	297	12.7k
Paresh Vyas	4.4k 0.6×	5.1k 0.7×	1.8k 0.8×	1.3k 0.7×	1.1k 0.7×	235	9.4k
D. Gary Gilliland	8.4k 1.1×	8.1k 1.1×	4.2k 1.9×	2.8k 1.4×	2.3k 1.4×	126	16.2k
Christine Chomienne	10.1k 1.4×	6.8k 0.9×	2.0k 0.9×	1.3k 0.7×	1.1k 0.7×	248	12.8k
Kevin Shannon	6.2k 0.8×	3.7k 0.5×	1.7k 0.8×	2.2k 1.1×	838 0.5×	276	12.5k
Tomoki Naoe	8.1k 1.1×	7.9k 1.1×	2.7k 1.2×	2.9k 1.4×	2.5k 1.5×	352	15.9k
Stephen D. Nimer	7.5k 1.0×	6.8k 0.9×	2.8k 1.3×	3.4k 1.7×	1.1k 0.7×	239	14.6k
Claus R. Bartram	3.8k 0.5×	4.1k 0.6×	2.1k 1.0×	1.7k 0.9×	2.9k 1.8×	212	10.0k
Francesco Lo‐Coco	11.3k 1.5×	11.2k 1.6×	2.6k 1.2×	2.7k 1.4×	3.4k 2.1×	276	18.0k
Scott C. Kogan	7.8k 1.0×	3.9k 0.5×	960 0.4×	1.8k 0.9×	617 0.4×	140	10.7k
Elisabeth Paietta	4.7k 0.6×	7.8k 1.1×	2.6k 1.2×	3.0k 1.5×	4.3k 2.7×	278	12.9k

Countries citing papers authored by Michael Lübbert

Since Specialization

Citations

This map shows the geographic impact of Michael Lübbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lübbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lübbert more than expected).

Fields of papers citing papers by Michael Lübbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lübbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lübbert. The network helps show where Michael Lübbert may publish in the future.

Co-authorship network of co-authors of Michael Lübbert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lübbert. A scholar is included among the top collaborators of Michael Lübbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lübbert. Michael Lübbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garcia‐Manero, Guillermo, et al.. (2025). DNA methyltransferase inhibitors in hematological malignancies and solid tumors. International Journal of Cancer. 158(2). 433–461. 1 indexed citations

Andrieux, Geoffroy, Gabriele Greve, Felicitas Thol, et al.. (2025). Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial. Leukemia. 39(11). 2816–2819.

Kelly, Katherine J., et al.. (2024). Genocopy of EVI1-AML with Paraneoplastic Diabetes Insipidus: PRDM16 Overexpression By t(1;2) and Enhancer Hijacking. Blood. 144(Supplement 1). 6136–6136.

Duque‐Afonso, Jesús, Jan Mitschke, Gabriele Greve, et al.. (2024). Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia. International Journal of Cancer. 155(11). 2068–2079.

Geißler, Klaus, Zdeněk Kořı́stek, Teresa Bernal, et al.. (2024). Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study. British Journal of Haematology. 205(5). 1734–1745. 8 indexed citations

Greve, Gabriele, Miguel Waterhouse, Robert Zeiser, et al.. (2023). Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. Cancers. 15(17). 4328–4328. 1 indexed citations

Greve, Gabriele, Geoffroy Andrieux, Pascal Schlosser, et al.. (2023). In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts. Leukemia. 37(5). 1018–1027. 2 indexed citations

Myacheva, Ksenia, et al.. (2023). Fast proliferating and slowly migrating non‐small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment. International Journal of Cancer. 154(6). 1029–1042. 7 indexed citations

Greve, Gabriele, Lars Feuerbach, Daniel B. Lipka, et al.. (2022). The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation. Blood Cancer Journal. 12(8). 122–122. 8 indexed citations

10.

Ruess, Dietrich Alexander, et al.. (2022). Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers. 14(23). 5926–5926. 12 indexed citations

11.

Pfeifer, Dietmar, Gabriele Ihorst, Nadja Blagitko‐Dorfs, et al.. (2021). Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients. Clinical Epigenetics. 13(1). 77–77. 18 indexed citations

12.

Greve, Gabriele, Dominica Willmann, Michael Müller, et al.. (2020). Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells. ChemBioChem. 21(16). 2329–2347. 17 indexed citations

13.

Mohr, Sebastian, Martin Schmitt, Alexandra Walter, et al.. (2017). LSD1 Inhibition Leads to Differentiation in Hoxa9/Meis1- but Not in MN1-Induced Acute Myeloid Leukemia. Blood. 130. 1246–1246. 1 indexed citations

14.

Rothenberg‐Thurley, Maja, Katarzyna Szarc vel Szic, Alexandra Nieters, et al.. (2017). Progression of Mds to Aml Features Gain of Single Driver Mutations with Consequent Changes in Clonal Composition and Occurrence of Multiple Clones with Mutations in Identical Genes. Haematologica.

15.

Schmoor, Claudia, Verena I. Gaidzik, Nadja Blagitko‐Dorfs, et al.. (2017). Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy. Annals of Hematology. 96(4). 559–565. 19 indexed citations

16.

Hackanson, Björn, Kristi L. Bennett, Romulo Martin Brena, et al.. (2008). Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid Leukemia. Cancer Research. 68(9). 3142–3151. 114 indexed citations

17.

Lübbert, Michael & P. Wijermans. (2005). Epigenetic therapy in MDS and acute AML: focus on decitabine. Annals of Hematology. 84(S1). 1–2. 9 indexed citations

18.

Guo, Yalin, Marie Follo, K. Geiger, Michael Lübbert, & Monika Engelhardt. (2003). Side-Population Cells from Different Precursor Compartments. Journal of Hematotherapy & Stem Cell Research. 12(1). 71–82. 24 indexed citations

19.

Lübbert, Michael, et al.. (2003). Acute myeloid leukemia of the elderly: results of induction after previous treatment of high-risk myelodysplastic syndrome with a demethylating agent. FreiDok plus (Universitätsbibliothek Freiburg). 1 indexed citations

20.

Lübbert, Michael, Augustin Ferrant, P. Wijermans, et al.. (2000). Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.. Blood. 96(11). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact